Assuring quality in an age of rapid technological advance

Stephen Leeder
Med J Aust 2015; 202 (8): 395-399. || doi: 10.5694/mja15.c0504
Published online: 4 May 2015

Can today's quest for innovation and efficiency in health care learn from the development of the laparascope?

The first series of over 100 patients in whom laparoscopic examination of the abdominal cavity was conducted safely was reported in 1910 by the Swedish surgeon Hans-Christian Jacobaeus,1,2 although, another surgeon, Georg Kelling of Dresden, subsequently claimed, somewhat miffed, that he pioneered the procedure in two patients in 1902 using a cystoscope.3

However, it was not until the 1930s that laparoscopy was used to support diagnostic biopsy. John Ruddock, a Californian cardiologist who became fascinated with the technique, reported hundreds of cases in which laparoscopy enabled high levels of diagnostic accuracy for hepatic and gastrointestinal disorders.4

Things were then quiet on the laparoscopic front until the introduction, in 1982, of a computer-chip camera into the laparoscope that revolutionised its use by projecting visual information, previously perceived only through one eye atop the laparoscope tube, onto a television screen in the operating theatre.

First in France in 1988, then in the rest of Europe and on into the United States, laparoscopic cholecystectomy became a frequent procedure. The spread of laparoscopic cholecystectomy was “like a wildfire”.5 Surgeons queued to be trained. Instrument companies went into overdrive developing laparoscopic equipment.

The demand from patients for this new procedure was intense. Strong competitive pressure drove hospitals to provide video facilities in operating theatres and expensive sets of laparoscopic instruments. Conservatives called for trials to compare the new versus the old way of excising diseased gall bladders, but since the 1990s, laparoscopic cholecystectomy has been the treatment of choice for uncomplicated gall bladder disease.6

New medical technologies

The story of laparoscopy is unusual. New technologies usually give only incremental advances and require sophisticated clinical trials to establish their superiority. But like penicillin, laparoscopy just took off.

Interestingly, while clinicians were intimately involved in developing technological innovations a century ago, we now depend heavily on technologies that are not medical or surgical in origin. Whether it is discerning the distinctive genetic profile of patients to better tailor therapy to their responsiveness, as seen increasingly in cancer chemotherapy, or understanding the neurophysiological basis of behavioural disturbance through magnetic resonance imaging, we use technology that brings other professionals into clinical care.

Medical advance and medical costs grow in synchrony with medically informing technologies and new drugs. Medical technology allows for safer, faster execution of care, often by less technically trained personnel, yet unlike in other technology-based industries — microcomputing, motor vehicles — the prices go up, not down.

While much of the steady rise in the costs of health care over the past 40 or more years has been attributed to the ageing of the population, economic analyses provide evidence that it is technology that is the principal inflator of cost.7

Tackling rising costs

What business model, to use the jargon, do we medicos propose for contending with the rising costs of health care? Our job is first and fundamentally to fulfil our duty of care to individual patients. But when the expense of doing that eats into our capacity to fulfil our duty of care to other patients, we have a problem. What can we suggest be done?

These are the facts: first, we are forever improving our treatment of illness and injuries, saving lives and relieving suffering. Second, this is the result of progress in our technological capacity to do so, most often driven by advances in the sciences beyond medicine — think information technology and 3-dimensional printing of prostheses. Third, while we need policies to guide health investment, these require serious contributions of evidence and opinion from the medical and surgical professions.

Also required is a forthright acknowledgement that some advances that, at first pass, appear to offer great benefit end up falling short of expectations when subjected to greater evidence-based scrutiny. Recent high-profile cases, such as the roles of vertebroplasty8 and renal denervation,9 are salient examples of the fact that the reversal of established medical practice is common and occurs across all fields of medicine.10

Our learned colleges could lead the way here. Analyses of what works in health care and what doesn't requires clinical reflection, and the colleges have a lot of firepower to bring to bear. Other analyses into ways to reduce the undesirable consequences of medical and surgical interventions, such as wound infection, also require professional leadership if they are to improve clinical practice.

The Choosing Wisely campaign in the US is a partnership of dozens of national organisations representing medical specialists and health care consumers working with the American Board of Internal Medicine Foundation “to help providers, patients and other health care stakeholders think and talk about overuse of health care resources in the United States”.11

This campaign has provoked the development of similar efforts in Australia, one sponsored by NPS MedicineWise,12 and a parallel “EVOLVE” initiative led by the Royal Australasian College of Physicians (RACP).13 They offer opportunites for the medical profession to lead the quest for more efficient care so that, with the resources saved, we can continue to innovate in the tradition of the development of laparoscopy. As Nick Talley, president of the RACP, said at a recent meeting of EVOLVE, clinicians can either lead — or wait to be led.

  • Stephen Leeder

  • Medical Journal of Australia, NSW.



I am grateful to Adam Elshaug of the Menzies Centre for Health Policy and Paul Gross of the Institute of Health Economics and Technology Assessment for their comments.

  • 1. Hatzinger M1, Häcker A, Langbein S, et al. Hans-Christian Jacobaeus (1879–1937): the inventor of human laparoscopy and thoracoscopy [German]. Urologe A 2006; 45: 1184-1186.
  • 2. Zucker KA, Bailey RW, Reddick EJ, editors. Surgical laparoscopy. St Louis, Mo: Quality Medical Publishing Inc, 1991.
  • 3. Schollmeyer T, Soyinka AS, Schollmeyer M, Meinhold-Heerlein I. Georg Kelling (1866 –1945): the root of modern day minimal invasive surgery. A forgotten legend? Arch Gynecol Obstet 276: 505-509.
  • 4. Litynski GS. Laparoscopy between the world wars: the barriers to trans-Atlantic exchange: spotlighting Heinz Kalk and John C. Ruddock. JSLS. 1997; 1: 185-188.
  • 5. Nagy AG, Patterson EJ. Laparascopic surgery: historical perspectives. In: Zucker A, editor. Surgical laparoscopy. 2nd ed. Philadelphia, Pa: Lippincott, Williams and Wilkins, 2001.
  • 6. Soper NJ, Stockmann PT, Dunnegan DL, Ashley SW. Laparoscopic cholecystectomy. The new “gold standard”? Arch Surg 1992; 127: 917-921.
  • 7. Smith S, Newhouse JP, Freeland MS. Income, insurance, and technology: why does health spending outpace economic growth? Health Aff (Millwood) 2009; 28: 1276-1284.
  • 8. Buchbinder R, Osborne RH, Kallmes D. Vertebroplasty appears no better than placebo for painful osteoporotic spinal fractures, and has potential to cause harm [editorial]. Med J Aust 2009; 191: 476-477.
  • 9. Shaw JA1, Warren JL. Resistant hypertension and renal denervation where to now? Cardiovasc Ther 2015; 33: 9-14.
  • 10. Prasad V, Vandross A, Toomey C, et al. A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin Proc 2013; 88: 790-798.
  • 11. Choosing wisely. An initiative of the ABIM Foundation. (accessed Mar 2015).
  • 12. NPS MedicineWise. Choosing Wisely Australia launching in 2015. (accessed Mar 2015).
  • 13. Royal Australasian College of Physicians. Evolve: evaluating evidence, enhancing efficiencies. (accessed Mar 2015).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

access_time 07:24, 4 May 2015
Rosemary Anne Jones

Dear Madam/Sir,
It is of interest that when a discussion on new surgical techniques is undertaken with reference to the laparoscope, it is always the success story of laparoscopic cholecystectomy that takes centre stage. Laparoscopic hysterectomy barely rates a mention despite established safety (Gynecological Surgery 2006;3(2):118-121) and reduced cost. It has the lowest total cost (JSLS 2014;18(4):e2014.00181). One wonders why this excellent procedure has remained the Cinderella of gynaecological surgery.
Dr Rosie Jones

Competing Interests: No relevant disclosures

Dr Rosemary Anne Jones
Adelaide Private Menopause Clinic

Online responses are no longer available. Please refer to our instructions for authors page for more information.